Cargando…
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
There is ample evidence that neoadjuvant chemotherapy of breast carcinoma is particularly efficient if the tumor presents signs of either a pre-existent or therapy-induced anticancer immune response. Antineoplastic chemotherapies are particularly beneficial if they succeed in inducing immunogenic ce...
Autores principales: | Stoll, Gautier, Enot, David, Mlecnik, Bernhard, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004621/ https://www.ncbi.nlm.nih.gov/pubmed/24790795 http://dx.doi.org/10.4161/onci.27884 |
Ejemplares similares
-
Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies
por: Stoll, Gautier, et al.
Publicado: (2015) -
Immune infiltrate in cancer
por: Stoll, Gautier, et al.
Publicado: (2015) -
Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts
por: Stoll, Gautier, et al.
Publicado: (2018) -
Immune sunrise: from the immunome to the cancer immune landscape
por: Bindea, Gabriela, et al.
Publicado: (2022) -
Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2013)